Patient Resources / Leptomeningeal Metastases
When cancer reaches the spinal fluid.
Leptomeningeal metastases (LM) happens when cancer spreads into the fluid that surrounds the brain and spinal cord. It can be serious, and it can be hard to catch. If you or someone you love is facing it, this page is here to help you understand LM in plain terms, and to find support.
Cancer in the Fluid
To understand LM, it helps to know where it lives.
The brain and spinal cord are bathed in cerebrospinal fluid (CSF). In leptomeningeal metastases, cancer cells, most often from a breast, lung, or melanoma tumor, spread into that fluid and the membranes around the brain and spine. LM can be hard to catch: symptoms are often subtle, imaging may look clear, and the usual spinal-fluid test can take several samples to find disease.
1. Batool A, Kasi A. Leptomeningeal carcinomatosis. StatPearls. Treasure Island (FL): StatPearls Publishing; 2023.
As many as 110,000 people in the U.S. are diagnosed with leptomeningeal metastases each year.1

“The most important thing is, you have to believe you can cure [LM]. Most people don’t. You have to believe you can cure it—and then you need to act like you can cure it.”
Peter Forsyth, MD
Neuro-Oncologist at Moffitt Cancer Center
How Cerenome is working on it.
LM is hard to treat because it lives in the spinal fluid, out of reach of surgery and of many treatments carried through the bloodstream, and because it’s so often found late. Cerenome works directly in that fluid, on both problems.
CNSide® analyzes cerebrospinal fluid to help detect, characterize, and monitor leptomeningeal metastases using cellular and molecular testing. REYOBIQ™, an investigational radiotherapeutic, is being studied for delivery directly into the cerebrospinal fluid through an Ommaya reservoir, with the goal of delivering radiation within the same CNS compartment where leptomeningeal disease is present.
These are investigational uses of REYOBIQ™. It is still being studied, and its safety and effectiveness have not been established. Your care team is the best guide to whether a clinical trial may be right for you.
Support & Resources
Where to learn more.
Signs and symptoms
Depending on where the cancer is in the CSF, LM can cause headaches, changes in thinking or memory, double or blurred vision, weakness or numbness, trouble with balance, or nausea. Symptoms can be subtle or come and go, which is part of why it’s hard to catch.
How it’s diagnosed
Diagnosis usually involves a neurological exam, an MRI of the brain and spine, and analysis of the CSF fluid, collected through a spinal tap (lumbar puncture or an Ommaya reservoir). Newer spinal-fluid tests can improve detection.
How it’s treated today
Treatment is tailored to each person and may include radiation to areas causing symptoms, chemotherapy given into the spinal fluid or through the body, and supportive care.
Questions to ask your care team
- Could a clinical trial be an option for me?
- What would taking part involve?
- How would treatment be given, and what should I expect?
Where to find support
- American Brain Tumor Association
- American Cancer Society
- Brain Tumor Network
- Dictionary of Cancer Terms
- End Brain Cancer Initiative
- Head for the Cure
- Leptomeningeal Cancer Foundation
- LUNGevity
- MedlinePlus (NIH)
- METAvivor
- National Brain Tumor Society
- National Cancer Institute
- National Comprehensive Cancer Network
- Support Groups Listing
- The Brain Tumour Charity
- VirtualTrials.org